D57.44
Sickle-cell thalassemia beta plus without crisis
Clinical Classification Guidelines
Inclusion Terms
- HbS-beta plus without crisis
- Sickle-cell beta plus without crisis
Medical Intelligence & Overview
Sickle-cell thalassemia beta plus without crisis is a chronic blood disorder characterized by abnormal hemoglobin production. This condition results from a combination of sickle-cell disease and beta thalassemia, two genetic blood disorders that affect hemoglobin, the protein in red blood cells responsible for carrying oxygen throughout the body. Unlike more severe forms of sickle-cell disease, this form does not typically lead to sudden and severe health episodes known as crises, but it still requires ongoing medical attention to manage symptoms and prevent complications.
Causes & Symptoms
Clinical Causes: Inherited genetic mutations in the HBB gene responsible for hemoglobin production. Combination of sickle-cell trait and beta thalassemia gene mutations. Autosomal recessive inheritance pattern, meaning both parents carry the gene and pass it to their child. No external environmental factors directly cause the disorder, although genetic predisposition is key.
Key Symptoms: Chronic anemia, leading to fatigue and weakness. Jaundice (yellowing of the skin and eyes). Delayed growth and development in children. Slight enlargement of the spleen. Frequent infections. Bone pain or deformities sometimes arising from marrow expansion.
Diagnostic & Treatment
Diagnosis Path: Blood tests, including complete blood count (CBC) to detect anemia. Hemoglobin electrophoresis to identify abnormal hemoglobin variants. DNA analysis to pinpoint specific genetic mutations. Additional tests may include reticulocyte count and bone marrow examination.
Treatment Protocols: Regular medical check-ups to monitor health status. Blood transfusions in certain cases to treat anemia. Folate supplements to support red blood cell production. Vaccinations and antibiotics to prevent infections. Hydroxyurea medication might be considered to reduce abnormal hemoglobin production. Avoidance of extreme physical stress and dehydration. Supportive care involving pain management when necessary.
Clinical Advice & FAQs
Billing Guidance
Is D57.44 a billable ICD-10 code?
Yes, D57.44 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D57.44?
Clinical documentation must specify the nature of Sickle-cell thalassemia beta plus without crisis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference